Universe Pharmaceuticals Inc (UPC) — Cash Flow Reinvestment Rate
Universe Pharmaceuticals Inc (UPC) has a Cash Flow Reinvestment Rate of 0.04x as of March 2025, reinvesting $96.78K (capex $96.78K ) from operating cash flow of $2.56 Million. Check Universe Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Universe Pharmaceuticals Inc Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Universe Pharmaceuticals Inc across 4 annual periods. Explore Universe Pharmaceuticals Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Universe Pharmaceuticals Inc (2018–2023)
Year-by-year capital reinvestment analysis for Universe Pharmaceuticals Inc. For live market cap and broader valuation context, see UPC market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.08x | $88.34K | $1.12 Million | $44.17K | ▲ +365.6% |
| 2020 | 0.02x | $103.60K | $6.12 Million | $51.80K | ▲ +29.8% |
| 2019 | 0.01x | $172.36K | $13.20 Million | $86.32K | ▼ -80.0% |
| 2018 | 0.07x | $290.19K | $4.46 Million | $145.09K | — |